Literature DB >> 33560566

Vulnerable areas to accidents with scorpions in Brazil.

Talita Ferreira Amado1,2, Thais Andrade Moura1, Pablo Riul3, André Felipe de Araujo Lira4, Raúl Badillo-Montaño5, Pablo Ariel Martinez1.   

Abstract

OBJECTIVE: To identify areas that present a higher risk of exposure to accidents with scorpions in Brazil.
METHODS: We used techniques of spatial prioritisation to determine the most vulnerable localities to envenomation by four scorpion species. Our prioritisation integrated ecological niche models with health investment, antivenin availability, access to health care facilities and metrics of human impact data.
RESULTS: The ecological niche models indicated that three scorpion species (Tityus bahiensis, Tityus serrulatus, and Tityus stigmurus) are more associated with human population density, while T. obscurus demonstrated a strong association with temperature variations during the year. Spatial prioritisation indicated that the areas with higher risk exposure to accidents with scorpions are in northern and northeastern Brazil. Alternatively, more isolated but densely populated areas in the southeastern and central regions also emerged as a priority.
CONCLUSION: Mapping areas where humans are more likely to interact with scorpions can assist in the design of efficient public health policies.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Tityuszzm321990; epidemiology; prioritisation; public health; serum; venom

Year:  2021        PMID: 33560566     DOI: 10.1111/tmi.13561

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  1 in total

1.  Scorpion envenomation in the state of São Paulo, Brazil: Spatiotemporal analysis of a growing public health concern.

Authors:  Alec Brian Lacerda; Camila Lorenz; Thiago Salomão De Azevedo; Denise Maria Cândido; Fan Hui Wen; Luciano José Eloy; Ana Aparecida Sanches Bersusa; Francisco Chiaravalloti Neto
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.